General

Showing 1521–1536 of 1897 results

Article: Phosphorylation of platelet acetyl-CoA carboxylase is increased in human and mice atherosclerosis and could be an indicator of persistent thrombin generation
€2.42 Add to cart
Article: Platelet Endothelial Aggregation Receptor 1: a novel modifier of neo-angiogenesis
€2.42 Add to cart
Article: PLATELET FUNCTION IN COAGULATION AND THROMBUS FORMATION
€2.42 Add to cart
Article: Platelets contribute to colitis-associated carcinogenesis: evidence from a mouse model
€2.42 Add to cart
Article: Plenary session at ASH 2016
€2.42 Add to cart
Article: Pneumatic tube transport is feasible for Rotem coagulation tests in a Central laboratory
€2.42 Add to cart
Article: Point of view about new guidelines on ESAs (erythropoiesis-stimulating agents)
€2.42 Add to cart
Article: Polyphosphate, a modulator of hemostasis and thrombosis: a novel target for antithrombotic agents?
€2.42 Add to cart
Article: POMALIDOMIDE ADDED TO BORTEZOMIB AND DEXAMETHASONE DELAYS DISEASE PROGRESSION IN THE SECOND-LINE TREATMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
€2.42 Add to cart
Article: Pomalidomide: a new hope for relapsed and refractory multiple myeloma
€2.42 Add to cart
Article: PP.01 The role of the de novo DNA methyltransferase DNMT3B in multiple myeloma cell survival and drug resistance
€2.42 Add to cart
Article: PP.02 Mild Cognitive Impairment, Hypoalbuminemia, High Crp And Gi Co-Morbidities: A Frailty Score That Identifies Older Patients With Malignant Hemopathies Who Don’t Benefit From Chemotherapy
€2.42 Add to cart
Article: PP.03 Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring: a standardized approach with underappreciated potential
€2.42 Add to cart
Article: PP.03.2 Improvement of antibody-induced cell death in multiple myeloma
€2.42 Add to cart
Article: PP.04 Loss of the tumor suppressor RASSF4 is associated with aggressive disease and poor outcome in Diffuse Large B Cell Lymphoma
€2.42 Add to cart
Article: PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
€2.42 Add to cart

Article: Phosphorylation of platelet acetyl-CoA carboxylase is increased in human and mice atherosclerosis and could be an indicator of persistent thrombin generation

Article: Platelet Endothelial Aggregation Receptor 1: a novel modifier of neo-angiogenesis

Article: PLATELET FUNCTION IN COAGULATION AND THROMBUS FORMATION

Article: Platelets contribute to colitis-associated carcinogenesis: evidence from a mouse model

Article: Plenary session at ASH 2016

Article: Pneumatic tube transport is feasible for Rotem coagulation tests in a Central laboratory

Article: Point of view about new guidelines on ESAs (erythropoiesis-stimulating agents)

Article: Polyphosphate, a modulator of hemostasis and thrombosis: a novel target for antithrombotic agents?

Article: POMALIDOMIDE ADDED TO BORTEZOMIB AND DEXAMETHASONE DELAYS DISEASE PROGRESSION IN THE SECOND-LINE TREATMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA

Article: Pomalidomide: a new hope for relapsed and refractory multiple myeloma

Article: PP.01 The role of the de novo DNA methyltransferase DNMT3B in multiple myeloma cell survival and drug resistance

Article: PP.02 Mild Cognitive Impairment, Hypoalbuminemia, High Crp And Gi Co-Morbidities: A Frailty Score That Identifies Older Patients With Malignant Hemopathies Who Don’t Benefit From Chemotherapy

Article: PP.03 Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring: a standardized approach with underappreciated potential

Article: PP.03.2 Improvement of antibody-induced cell death in multiple myeloma

Article: PP.04 Loss of the tumor suppressor RASSF4 is associated with aggressive disease and poor outcome in Diffuse Large B Cell Lymphoma

Article: PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura